Catherine Ledent Selected Research

Catherine Ledent Research Topics

Disease

8	Pain (Aches) 07/2011 - 03/2002
7	Inflammation (Inflammations) 10/2021 - 04/2005
5	Multiple Sclerosis 01/2014 - 03/2002
4	Substance-Related Disorders (Drug Abuse) 04/2014 - 03/2003
4	Huntington Disease (Huntington's Disease) 06/2011 - 01/2007
4	Ischemia 10/2010 - 03/2003
3	Asthma (Bronchial Asthma) 01/2020 - 06/2007
3	Hyperemia 01/2017 - 05/2013
3	Seizures (Absence Seizure) 01/2011 - 07/2008
3	Alcoholism (Alcohol Abuse) 08/2007 - 02/2004
3	Hyperalgesia 01/2006 - 11/2002
2	Fibrosis (Cirrhosis) 07/2015 - 06/2006
2	Parkinsonian Disorders (Parkinsonism) 01/2015 - 11/2014
2	Hypothermia 01/2014 - 12/2002
2	Heart Failure 09/2013 - 12/2012
2	Mental Disorders (Mental Disorder) 08/2013 - 07/2012
2	Body Weight (Weight, Body) 12/2012 - 04/2008
2	Peripheral Nerve Injuries 07/2011 - 11/2008
2	Neuralgia (Stump Neuralgia) 07/2011 - 01/2006
2	Gliosis 04/2011 - 04/2007
2	Epilepsy (Aura) 01/2011 - 09/2009
2	Infarction (Infarctions) 10/2010 - 03/2007
2	Atrophy 04/2008 - 01/2007
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2006 - 06/2006
1	Pneumonia (Pneumonitis) 01/2020
1	Hyperglycemia 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Myocarditis (Carditis) 01/2017
1	Parkinson Disease (Parkinson's Disease) 11/2014
1	Endotoxemia 07/2013
1	Congenital Abnormalities (Deformity) 03/2012
1	Hypersensitivity (Allergy) 07/2011
1	Dyskinesias (Dyskinesia) 04/2011
1	Neuroinflammatory Diseases 04/2011
1	Sclerosis 01/2011
1	Temporal Lobe Epilepsy 01/2011
1	Ischemic Stroke 03/2010
1	Brain Ischemia (Cerebral Ischemia) 03/2010
1	Male Infertility (Male Sterility) 02/2010

Drug/Important Bio-Agent (IBA)

14	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 11/2002
14	CannabinoidsIBA 01/2019 - 03/2002
11	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019 - 02/2005
11	EndocannabinoidsIBA 01/2018 - 03/2002
10	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2021 - 03/2002
8	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 06/2007
8	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2017 - 12/2002
4	Ethanol (Ethyl Alcohol)IBA 08/2007 - 12/2002
3	Morphine (MS Contin)FDA LinkGeneric 07/2011 - 04/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2012
2	RimonabantIBA 07/2015 - 06/2006
2	Caffeine (No Doz)FDA LinkGeneric 11/2014 - 07/2008
2	KATP ChannelsIBA 10/2014 - 05/2013
2	Adenosine Triphosphate (ATP)IBA 10/2014 - 05/2013
2	TRPV Cation ChannelsIBA 08/2013 - 03/2002
2	Glutamic Acid (Glutamate)FDA Link 07/2012 - 04/2007
2	Opioid Receptors (Opioid Receptor)IBA 07/2011 - 10/2005
2	Pilocarpine (Ocusert)FDA LinkGeneric 01/2011 - 09/2009
2	Pentylenetetrazole (Metrazol)IBA 09/2009 - 07/2008
2	Analgesics (Analgesic Drugs)IBA 09/2008 - 03/2002
2	AM 251 (AM251)IBA 09/2008 - 11/2002
2	N-Methylaspartate (NMDA)IBA 12/2007 - 08/2007
2	Opioid Analgesics (Opioids)IBA 10/2005 - 11/2002
1	EnzymesIBA 10/2021
1	CollagenIBA 10/2021
1	AntioxidantsIBA 10/2021
1	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 01/2020
1	LimoneneIBA 01/2020
1	AerosolsIBA 01/2020
1	OvalbuminIBA 01/2020
1	Terpenes (Terpenoids)IBA 01/2020
1	Methacholine Chloride (Methacholine)FDA Link 01/2020
1	Insulin (Novolin)FDA Link 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	OxylipinsIBA 01/2017
1	4- (4- (3- adamantan- 1- ylureido)cyclohexyloxy)benzoic acidIBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017
1	Apelin ReceptorsIBA 01/2017
1	Epoxide HydrolasesIBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2015
1	Dopamine (Intropin)FDA LinkGeneric 01/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 04/2014
1	NeuropeptidesIBA 04/2014
1	Ligand-Gated Ion ChannelsIBA 08/2013
1	LipopolysaccharidesIBA 07/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2013
1	AllergensIBA 02/2013
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2012
1	Cocaine (Cocaine HCl)IBA 10/2012
1	Cannabinoid Receptor AgonistsIBA 03/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2011
1	Oxidopamine (6 Hydroxydopamine)IBA 04/2011
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 04/2011
1	Levodopa (L Dopa)FDA LinkGeneric 04/2011
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2010
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 03/2010

Therapy/Procedure

4	Therapeutics 11/2014 - 03/2007
2	Analgesia 07/2011 - 09/2008
2	Ligation 07/2011 - 05/2006